Not Signed In -
Paroxetine |
Paxil; Paxil CR |
Clinical Trial: Biological Aspects of Depression and Antidepressant Drugs
This study has been completed.
|
Purpose
This study will be measuring changes in depressive symptoms over a 7 week time period. Double-blind placebo controlled trial using the pharmacologic agents Paroxetine or Desipramine.
| Condition | Treatment or Intervention |
|---|---|
| Depression | Drug: paroxetine Drug: Desipramine |
MedlinePlus related topics: Depression
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Pharmacodynamics Study
Further Study Details:
Study start: September 1996; Study completion: December 2001
Eligibility
Ages Eligible for Study: 21 Years - 69 Years, Genders Eligible for Study: Both
Accepts Healthy Volunteers
Criteria
- Diagnosis of major depressive disorder Ham-D Score > 18
- English speaking with ability to read and sign an informed consent
Location Information
Texas
South Texas Veterans Health Care System, San Antonio, Texas, 78229, United States
Study chairs or principal investigators
Steve Brannan, M.D.
Cheryl Gonzalez, M.D.
More Information
Study ID Numbers: MHBS-031-99F
Record last reviewed: December 2004
Last Updated: December 30, 2004
Record first received: July 3, 2001
ClinicalTrials.gov Identifier: NCT00018733
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: December 2004
Last Updated: December 30, 2004
Record first received: July 3, 2001
ClinicalTrials.gov Identifier: NCT00018733
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 8, 2005
Resources
- Paroxetine (Drug Digest)
- Paxil (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
